Suchergebnisse - "Tubb, Vanessa"

  • Treffer 1 - 7 von 7
Treffer weiter einschränken
  1. 1

    Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies von Tubb, Vanessa M., Schrikkema, Deborah S., Croft, Nathan P., Purcell, Anthony W., Linnemann, Carsten, Freriks, Manon R., Chen, Frederick, Long, Heather M., Lee, Steven P., Bendle, Gavin M.

    ISSN: 2051-1426, 2051-1426
    Veröffentlicht: London BioMed Central 13.07.2018
    Veröffentlicht in Journal for immunotherapy of cancer (13.07.2018)
    “… Mutation-derived neoantigens represent an important class of tumour-specific, tumour rejection antigens, and are attractive targets for TCR gene therapy of …”
    Volltext
    Journal Article
  2. 2

    Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity von Fultang, Livingstone, Booth, Sarah, Yogev, Orli, Martins da Costa, Barbara, Tubb, Vanessa, Panetti, Silvia, Stavrou, Victoria, Scarpa, Ugo, Jankevics, Andris, Lloyd, Gavin, Southam, Andrew, Lee, Steven P, Dunn, Warwick B, Chesler, Louis, Mussai, Francis, De Santo, Carmela

    ISSN: 1528-0020, 1528-0020
    Veröffentlicht: United States 03.09.2020
    Veröffentlicht in Blood (03.09.2020)
    “… Hematological and solid cancers catabolize the semiessential amino acid arginine to drive cell proliferation. However, the resulting low arginine …”
    Weitere Angaben
    Journal Article
  3. 3

    The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated‐recombinant arginase I BCT‐100 von De Santo, Carmela, Booth, Sarah, Vardon, Ashley, Cousins, Antony, Tubb, Vanessa, Perry, Tracey, Noyvert, Boris, Beggs, Andrew, Ng, Margaret, Halsey, Christina, Kearns, Pamela, Cheng, Paul, Mussai, Francis

    ISSN: 0020-7136, 1097-0215, 1097-0215
    Veröffentlicht: United States Wiley Subscription Services, Inc 01.04.2018
    Veröffentlicht in International journal of cancer (01.04.2018)
    “… Arginine is a semi‐essential amino acid that plays a key role in cell survival and proliferation in normal and malignant cells. BCT‐100, a pegylated (PEG) …”
    Volltext
    Journal Article
  4. 4
  5. 5

    346 Pre-clinical characterization of AZD0240, a CRISPR-engineered autologous TCR-T cell product targeting KRAS-G12D/HLA-A11:01 that is multi-armored to increase epitope sensitivity von Kok Lianne, Eshuis Sander, Kong Xiangjun, Ma, Jennifer, Mojadidi Michelle, Hall, Elizabeth, Grace Sun Ka Hei, Kroon, Paula, Tubb, Vanessa, Schumacher, Ton, Perez, Arianne, Linnemann Carsten, Cobbold, Mark, Heijst Jeroen van, Bendle Gavin

    ISSN: 2051-1426
    Veröffentlicht: London BMJ Publishing Group LTD 01.11.2025
    Veröffentlicht in Journal for immunotherapy of cancer (01.11.2025)
    “… BackgroundKRAS is one of the most mutated genes in human cancer, with the G12D mutation having the highest frequency, occurring in 28% and 12% of pancreatic …”
    Volltext
    Journal Article
  6. 6

    The development of novel t cell receptor, and chimeric antigen receptor, engineered t cell therapies for the treatment of cancer von Tubb, Vanessa

    Veröffentlicht: ProQuest Dissertations & Theses 01.01.2017
    “… The ability to generate a tumour-reactive T cell compartment is possible through the genetic engineering of patient T cells with tumour-reactive TCRs or CARs …”
    Volltext
    Dissertation
  7. 7

    Project 1: the role of PTPN22.6 in intermediate uveitis and Project 2: cord blood mononuclear cells as an alternative source for chimeric antigen receptor-mediated cancer immunotherapy von Tubb, Vanessa

    Veröffentlicht: ProQuest Dissertations & Theses 01.01.2013
    “… Project 1. BACKGROUND: Uveitis, an inflammatory disease with a putative autoimmune component, is a major cause of visual impairment in the UK. Lyp is a protein …”
    Volltext
    Dissertation